Related Experiment Videos
Use of bisphosphonates in the treatment of prostate cancer
1University of Michigan, Comprehensive Cancer Center, USA.
Oncology (Williston Park, N.Y.)
|October 18, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.
Proceedings of the National Academy of Sciences of the United States of America·2021
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy.
Seminars in cancer biology·2020
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer.
Medical oncology (Northwood, London, England)·2020
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.
Prostate cancer and prostatic diseases·2016
Detection of apoptosis in renal cell carcinoma.
Methods in molecular medicine·2011
Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.
Oncology (Williston Park, N.Y.)·2026
Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.
Oncology (Williston Park, N.Y.)·2026
Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.
Oncology (Williston Park, N.Y.)·2026
Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.
Oncology (Williston Park, N.Y.)·2026
Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.
Oncology (Williston Park, N.Y.)·2026
In vivo and computational investigation of the antidepressant-like activity of boldine from Peumus boldus in mice subjected to chronic unpredictable mild stress.
Pharmacology, biochemistry, and behavior·2026
Drug discrimination distinguishes pharmacologically distinct κ-opioid receptor agonists in rats.
European journal of pharmacology·2026
Lycopus lucidus Extract Attenuates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Pharmaceuticals (Basel, Switzerland)·2026